FDA Grants Orphan Drug Designation for the Treatment of Scleroderma
/PRNewswire/ -- BLR Bio, an emerging biotechnology company in Rosalind Franklin Universitys Helix 51 biomedical incubator, announced that the U.S. Food and...
Ronald Kaplan Drug Administration Canadian Institutes Of Health Research Rosalind Franklin University Of Medicine University Of Saskatchewan National Scleroderma Foundation
Source: prnewswire.com